Dr. Joshua Michael Davidson, MD

Dr. Davidson practices at BronxCare Ambulatory Care Network in Bronx, New York.

Dr. Davidson's NPI, 1376954560, was assigned on May 11, 2014. Dr. Davidson holds New York license 303030.

Dr. Davidson's primary practice is BronxCare Ambulatory Care Network, at 1650 Grand Concourse FL 14, Bronx, NY 10457 in Bronx County. The practice phone is (718) 518-5000.

Dr. Davidson's primary practice is BronxCare Ambulatory Care Network in Bronx, New York. Dr. Davidson is also affiliated with BronxCare Hospital Center. The medical group on file is BronxCare Health System. Dmand AI also links Dr. Davidson to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davidson practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Davidson's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Davidson is licensed in New York.

CMS data shows 269 Medicare services from Dr. Davidson across 6 procedure codes in 2024, for 150 Medicare patients. Medicare paid $35,645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Davidson in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 66% have diabetes. 90% are also on Medicaid. Their average risk score is 3.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Davidson's median patient age at 63, with 59% women.

In 2024, Dr. Davidson wrote 1,565 Medicare Part D claims for 216 patients. CMS names the drug for 1,446 of them, across 19 drugs with 11 or more claims each, at $407,251 in total drug cost. In 2023, CMS named 1,230 claims across 15 drugs.

Dr. Davidson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 48 general payments to Dr. Davidson from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $524.